ClinicalTrials.Veeva

Menu

The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease (ω3CD)

Zhejiang University logo

Zhejiang University

Status and phase

Unknown
Phase 4

Conditions

Crohn Disease

Treatments

Procedure: Intestinal surgery for Crohn's Disease
Drug: ω-3 polyunsaturated fatty acid

Study type

Interventional

Funder types

Other

Identifiers

NCT03901937
SRRSH20180925-8

Details and patient eligibility

About

This study is intended to investigate the safety and efficacy of ω-3 polyunsaturated fatty acid-based parenteral nutrition (PN) for patients with Crohn's disease.

Enrollment

158 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosis as Crohn's disease according to definition;
  2. Bowel resection;
  3. With parenteral nutrition at least 5 days
  4. 18 years old<age<75 years old;
  5. Sign the informed consent.

Exclusion criteria

  1. Emergency surgery;
  2. With severe comorbidity and/or organ (kidney,liver,or heart) dysfunction;
  3. Incomplete laboratory data;
  4. With parenteral nutrition before surgery;
  5. Pregnant;
  6. Allergy of ω-3 polyunsaturated fatty acid.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

158 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
parenteral nutrition without ω-3 polyunsaturated fatty acid
Treatment:
Drug: ω-3 polyunsaturated fatty acid
Procedure: Intestinal surgery for Crohn's Disease
ω-3 fatty acid
Experimental group
Description:
parenteral nutrition with ω-3 polyunsaturated fatty acid
Treatment:
Procedure: Intestinal surgery for Crohn's Disease

Trial contacts and locations

1

Loading...

Central trial contact

Wei Zhou, MD PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems